11890
A. Russo et al. / Tetrahedron 63 (2007) 11886–11892
4.2.10. (2S,10R)-2-(Hydroxy-(o-chlorophenyl)methyl)-
cyclohexan-1-one (Table 2, entry 8).4f [a]D22 +10.2 (c
1.01, CHCl3), 90% ee. anti-Isomer: H NMR (400 MHz,
3.46 (t, J¼9.9 Hz, 1H, CH), 3.70–3.83 (m, 3H, CH2 and
OH), 4.18–4.23 (m, 1H, CH), 4.96 (dd, J¼3.3, 8.1 Hz, 1H,
CHOH), 7.50 (d, J¼8.7 Hz, 2H, ArH), 8.21 (d, J¼8.7 Hz,
2H, ArH). The ee was determined by HPLC with Chiralpak
AD column (80/20 hexane/2-propanol), 254 nm, 1.0 mL/
min, tr¼25.0 min (major), tr¼21.9 min (minor).
4.2.15. (3S,10R)-3-(Hydroxy-(p-nitrophenyl)methyl)-tet-
rahydrothiopyran-4-one (Table 2, entry 13).4g,9d [a]D30
+3.0 (c 0.7, CHCl3), 94% ee. anti-Isomer: 1H NMR
(400 MHz, CDCl3): d 2.51–2.55 (m, 1H, CH), 2.64–2.70
(m, 1H, CH), 2.74–2.88 (m, 2H, CH2), 2.97–3.05 (m, 3H,
CH2 and CH), 3.68 (br s, 1H, OH), 5.06 (d, J¼8.0 Hz, 1H,
CHOH), 7.55 (d, J¼8.8 Hz, 2H, ArH), 8.23 (d, J¼8.8 Hz,
2H, ArH). The ee was determined by HPLC with Chiralpak
AD column (90/10 hexane/2-propanol), 254 nm, 1 mL/min;
tr¼75.6 min (major), tr¼42.4 min (minor).
4.2.16. (3S,10R)-3-(Hydroxy-(o-nitrophenyl)methyl)-tet-
rahydrothiopyran-4-one (Table 2, entry 14).4g [a]D25 +7.2
(c 0.74, CHCl3), 93% ee. anti-Isomer: 1H NMR
(400 MHz, CDCl3): d 2.61 (dt, J¼13.6, 3.2 Hz, 1H, CH),
2.72–3.06 (m, 5H, 2 CH2 and CH), 3.14–3.20 (m, 1H,
CH), 3.83 (br s, 1H, OH), 5.56 (d, J¼7.2 Hz, 1H, CHOH),
7.46 (t, J¼8.0 Hz, 1H, ArH), 7.67 (t, J¼7.6 Hz, 1H, ArH),
7.77 (d, J¼7.6 Hz, 1H, ArH), 7.89 (d, J¼8.4 Hz, 1H,
ArH). The ee was determined by HPLC with Chiralpak
AD column (90/10 hexane/2-propanol), 254 nm, 1 mL/
min, tr¼41.4 min (major), tr¼33.7 min (minor).
1
CDCl3): d 1.51–2.09 (m, 6H, 3 CH2), 2.28–2.46 (m, 2H,
CH2), 2.63–2.70 (m, 1H, CH), 3.92 (s, 1H, OH), 5.34 (d,
J¼8.0 Hz, 1H, CHOH), 7.19 (t, J¼7.6 Hz, 1H, ArH), 7.28
(d, J¼7.6 Hz, 1H, ArH), 7.31 (d, J¼8.0 Hz, 1H, ArH),
7.53 (d, J¼7.6 Hz, 1H, ArH). The ee was determined by
HPLC with a Chiralcel OD column (95/5 hexane/2-propa-
nol), 220 nm, 0.8 mL/min; tr¼11.5 min (major),
tr¼13.3 min (minor).
4.2.11. (2S,10R)-2-[Hydroxy-(5-nitrofuran-2-yl)methyl]-
cyclohexan-1-one (Table 2, entry 9).18 [a]D24 +14.0
(c 2.15, CHCl3), 79% ee. anti-Isomer: 1H NMR
(400 MHz, CDCl3): d 1.59–1.79 (m, 3H, CH2 and one proton
of CH2), 1.89–1.95 (m, 2H, CH2), 2.14–2.18 (m, 1H, one
proton of CH2), 2.37–2.50 (m, 2H, CH2), 2.95–3.00 (m,
1H, CH), 4.02 (br s, 1H, OH), 4.82 (d, J¼6.5 Hz, 1H,
CHOH), 6.59 (d, J¼3.6 Hz, 1H, ArH), 7.28 (d, J¼3.6 Hz,
1H, ArH); 13C NMR (100.1 MHz, CDCl3): 24.6, 27.7,
30.8, 42.6, 54.3, 68.8, 110.5, 112.4, 151.6, 158.4, 214.2.
The ee was determined by HPLC with Chiralpak AD column
(95/5
hexane/2-propanol),
254 nm,
1.0 mL/min,
tr¼36.5 min (major), tr¼43.3 min (minor).
4.2.12. 2-(Hydroxy-(p-nitrophenyl)methyl)cyclopentan-
1-one (Table 2, entry 10).4e anti-Isomer: 1H NMR
(300 MHz, CDCl3): d 1.50–2.03 (m, 4H, 2 CH2), 2.25–2.48
(m, 3H, CH2 and CH), 4.78 (s, 1H, OH), 4.84 (d, J¼4.6 Hz,
1H, CHOH), 7.54 (d, J¼4.3 Hz, 2H, ArH), 8.21(d,
J¼4.3 Hz, 2H, ArH). syn-isomer: 1H NMR (300 MHz,
CDCl3): d 1.60–2.20 (m, 4H, 2 CH2), 2.30–2.50 (m, 2H,
CH2), 2.65 (d, J¼2.4 Hz, 1H, CH), 5.42 (s, 1H, CHOH),
7.52 (d, J¼4.4 Hz, 2H, ArH), 8.20 (d, J¼4.4 Hz, 2H, ArH).
The ee was determined by HPLC with Chiralpak AS-H
column (70/30 hexane/2-propanol), 254 nm, 1.0 mL/min,
syn-isomer: tr¼20.8 min (major), tr¼7.6 min (minor); anti-
isomer: tr¼17.3 min (major), tr¼13.8 min (minor).
4.2.17. (3S,10R)-3-(Hydroxy-(p-cyanophenyl)methyl)-tet-
rahydrothiopyran-4-one (Table 2, entry 15).4g [a]D24 +8.0
(c 0.78, CHCl3), 90% ee. anti-Isomer: H NMR (400 MHz,
1
CDCl3): d 2.52 (ddd, J¼13.6, 4.8, 2.0 Hz, 1H, CH), 2.63
(dd, J¼13.6, 10.4 Hz, 1H, CH), 2.73–3.03 (m, 5H, 2 CH2
and CH), 3.69 (br s, 1H, OH), 5.02 (d, J¼8.0 Hz, 1H,
CHOH), 7.48 (d, J¼8.0 Hz, 2H, ArH), 7.67 (d, J¼8.4 Hz,
2H, ArH). The ee was determined by HPLC with Chiralcel
OD column (92/8 hexane/2-propanol), 254 nm, 1 mL/min;
tr¼43.6 min (major), tr¼61.1 min (minor).
4.2.18. (3S,10R)-3-(Hydroxy-(p-(trifluoromethyl)phenyl)-
methyl)-tetrahydrothiopyran-4-one (Table 2, entry
16).9d [a]D25 +4.4 (c 0.77, CHCl3), 90% ee. 1H NMR
(400 MHz, CDCl3): d 2.51 (ddd, J¼13.7, 4.9, 2.2 Hz, 1H,
CH), 2.63 (dd, J¼13.7, 10.6 Hz, 1H, CH), 2.77 (ddd,
J¼13.5, 10.2, 5.8 Hz, 1H, CH), 2.84 (dt, J¼13.5, 4.2 Hz,
1H, CH), 2.93–3.04 (m, 3H, CH2 and CH), 3.54 (d,
J¼3.7 Hz, 1H, OH), 5.04 (dd, J¼8.4, 3.7 Hz, 1H, CHOH),
7.48 (d, J¼8.3 Hz, 2H, ArH), 7.63 (d, J¼8.3 Hz, 2H,
ArH). The ee was determined by HPLC with a Chiralpak
OD column (90/10 hexane/2-propanol), 220 nm, 0.7 mL/
min; tr¼21.8 min (major), tr¼34.4 min (minor).
4.2.13. 2-(Hydroxy-(o-nitrophenyl)methyl)cyclopentan-
1-one (Table 2, entry 11).4h anti-Isomer: 1H NMR
(400 MHz, CDCl3): d 1.70–2.03 (m, 4H, 2 CH2), 2.19–
2.38 (m, 2H, CH2), 2.68 (d, J¼7.6 Hz, 1H, CH), 2.90 (br
s, 1H, OH), 5.21 (d, J¼7.2 Hz, 1H, CHOH), 7.44 (t,
J¼8.0 Hz, 1H, ArH), 7.66 (t, J¼8.0 Hz, 1H, ArH), 7.89 (d,
J¼8.0 Hz, 1H, ArH), 8.00 (dd, J¼8.0, 0.8 Hz, 1H, ArH).
1
syn-Isomer: H NMR (400 MHz, CDCl3): d 1.70–1.78 (m,
2H, CH2), 2.03–2.19 (m, 3H, CH2 and CH), 2.37 (dd,
J¼8.0, 1.6 Hz, 1H, CH), 2.60 (br s, 1H, OH), 2.74 (m, 1H,
CH,), 5.92 (d, J¼2.4 Hz, 1H, CHOH), 7.44 (td, J¼8.0,
0.8 Hz, 1H, ArH), 7.66 (t, J¼8.0 Hz, 1H, ArH), 7.89 (d,
J¼8.0 Hz, 1H, ArH), 8.02 (d, J¼8.0 Hz, 1H, ArH). The ee
was determined by HPLC with Chiralpak AS-H column
(95/5 hexane/2-propanol), 254 nm, 1.0 mL/min; syn-isomer:
tr¼35.1 min (major), tr¼25.8 min (minor); anti-isomer:
tr¼43.3 min (major), tr¼36.9 min (minor).
4.2.14. (3S,10R)-3-(Hydroxy-(p-nitrophenyl)methyl)-tet-
rahydropyran-4-one (Table 2, entry 12).4g [a]D26 +1.0
(c 1.86, CHCl3), 70% ee. anti-Isomer: 1H NMR (300 MHz,
CDCl3): d 2.50–2.54 (m, 1H, one proton of CH2), 2.66–
2.69 (m, 1H, one proton of CH2), 2.88–2.90 (m, 1H, CH),
4.2.19. (3S,4S)-3-Methoxy-4-(p-nitrophenyl)-butan-2-
one (Table 3, entry 1).8d,15 [a]D25 ꢁ8.4 (c 0.21, CHCl3),
1
84% ee. anti-Isomer: H NMR (400 MHz, CDCl3): d 2.17
(s, 3H, CH3CO), 3.14 (d, J¼3.7 Hz, 1H, OH), 3.33 (s, 3H,
OCH3), 3.71 (d, J¼6.2 Hz, 1H, CH), 5.03 (dd, J¼6.2,
3.7 Hz, 1H, CHOH), 7.57 (d, J¼8.7 Hz, 2H, ArH), 8.23 (d,
J¼8.7 Hz, 2H, ArH). The ee was determined by HPLC with
a Chiralpak OD column (90/10 hexane/2-propanol), 254 nm,
0.8 mL/min; tr¼15.8 min (major), tr¼18.8 min (minor).